Pacific Biosciences of California, Inc. (PACB) DCF Valuation
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Pacific Biosciences of California, Inc. (PACB) Bundle
Save time and improve precision with our (PACB) DCF Calculator! Equipped with real data from Pacific Biosciences of California, Inc. and customizable assumptions, this tool enables you to forecast, analyze, and value (PACB) just like a seasoned investor.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 90.9 | 78.9 | 130.5 | 128.3 | 200.5 | 254.1 | 321.9 | 407.9 | 516.8 | 654.9 |
| Revenue Growth, % | 0 | -13.2 | 65.43 | -1.69 | 56.29 | 26.71 | 26.71 | 26.71 | 26.71 | 26.71 |
| EBITDA | -71.6 | 39.0 | -250.8 | -282.2 | -277.3 | -167.4 | -212.0 | -268.7 | -340.4 | -431.3 |
| EBITDA, % | -78.75 | 49.4 | -192.13 | -219.98 | -138.28 | -65.87 | -65.87 | -65.87 | -65.87 | -65.87 |
| Depreciation | 9.9 | 9.3 | 11.6 | 17.3 | 26.5 | 29.6 | 37.6 | 47.6 | 60.3 | 76.4 |
| Depreciation, % | 10.94 | 11.79 | 8.88 | 13.5 | 13.23 | 11.67 | 11.67 | 11.67 | 11.67 | 11.67 |
| EBIT | -81.5 | 29.7 | -262.3 | -299.6 | -303.8 | -178.9 | -226.7 | -287.2 | -363.9 | -461.1 |
| EBIT, % | -89.69 | 37.61 | -201.01 | -233.48 | -151.51 | -70.42 | -70.42 | -70.42 | -70.42 | -70.42 |
| Total Cash | 49.1 | 318.8 | 1,044.4 | 772.3 | 631.4 | 230.7 | 292.3 | 370.4 | 469.3 | 594.6 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 15.3 | 16.8 | 24.2 | 18.8 | 36.6 | 45.5 | 57.7 | 73.1 | 92.6 | 117.4 |
| Account Receivables, % | 16.8 | 21.34 | 18.57 | 14.64 | 18.26 | 17.92 | 17.92 | 17.92 | 17.92 | 17.92 |
| Inventories | 13.3 | 14.2 | 24.6 | 50.4 | 56.7 | 60.5 | 76.7 | 97.1 | 123.1 | 155.9 |
| Inventories, % | 14.65 | 18.04 | 18.85 | 39.27 | 28.26 | 23.81 | 23.81 | 23.81 | 23.81 | 23.81 |
| Accounts Payable | 8.4 | 3.6 | 11.0 | 12.0 | 15.1 | 19.8 | 25.1 | 31.9 | 40.4 | 51.2 |
| Accounts Payable, % | 9.21 | 4.54 | 8.43 | 9.37 | 7.51 | 7.81 | 7.81 | 7.81 | 7.81 | 7.81 |
| Capital Expenditure | -2.8 | -1.0 | -5.9 | -16.9 | -8.8 | -13.5 | -17.1 | -21.7 | -27.5 | -34.8 |
| Capital Expenditure, % | -3.12 | -1.32 | -4.54 | -13.19 | -4.41 | -5.32 | -5.32 | -5.32 | -5.32 | -5.32 |
| Tax Rate, % | 3.59 | 3.59 | 3.59 | 3.59 | 3.59 | 3.59 | 3.59 | 3.59 | 3.59 | 3.59 |
| EBITAT | -75.4 | 29.7 | -173.0 | -283.0 | -292.9 | -160.8 | -203.7 | -258.1 | -327.0 | -414.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -88.5 | 30.7 | -177.7 | -302.0 | -296.3 | -152.6 | -206.3 | -261.4 | -331.2 | -419.6 |
| WACC, % | 7.41 | 7.63 | 6.63 | 7.47 | 7.53 | 7.33 | 7.33 | 7.33 | 7.33 | 7.33 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1,076.7 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -428 | |||||||||
| Terminal Value | -8,026 | |||||||||
| Present Terminal Value | -5,634 | |||||||||
| Enterprise Value | -6,711 | |||||||||
| Net Debt | 754 | |||||||||
| Equity Value | -7,465 | |||||||||
| Diluted Shares Outstanding, MM | 254 | |||||||||
| Equity Value Per Share | -29.43 |
What You Will Get
- Real PACB Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures to fit your analysis.
- Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Analysis: Evaluate various scenarios to assess the future performance of Pacific Biosciences.
- User-Friendly Design: Designed for professionals while remaining approachable for newcomers.
Key Features
- Comprehensive PACB Data: Pre-filled with Pacific Biosciences' historical financials and future projections.
- Fully Customizable Inputs: Modify revenue growth rates, profit margins, WACC, tax rates, and capital expenditures.
- Dynamic Valuation Model: Instant updates to Net Present Value (NPV) and intrinsic value based on your adjustments.
- Scenario Testing: Develop multiple forecasting scenarios to explore various valuation results.
- User-Friendly Interface: Intuitive design that caters to both professionals and novices.
How It Works
- Download the Template: Gain immediate access to the Excel-based PACB DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and more.
- Instant Calculations: The model automatically recalculates the intrinsic value of Pacific Biosciences.
- Test Scenarios: Experiment with different assumptions to assess potential valuation variations.
- Analyze and Decide: Leverage the results to inform your investment or financial strategy.
Why Choose This Calculator for Pacific Biosciences (PACB)?
- Accuracy: Utilizes real Pacific Biosciences financial data for precise calculations.
- Flexibility: Allows users to easily adjust and test various input parameters.
- Time-Saving: Eliminate the need to construct a DCF model from the ground up.
- Professional-Grade: Crafted with the precision and usability expected by financial executives.
- User-Friendly: Designed for ease of use, suitable for users with varying levels of financial expertise.
Who Should Use This Product?
- Investors: Assess Pacific Biosciences’ valuation before making stock transactions.
- CFOs and Financial Analysts: Optimize valuation methodologies and evaluate forecasts.
- Startup Founders: Understand the valuation processes of leading biotech firms like Pacific Biosciences.
- Consultants: Provide expert valuation analyses and reports for clients in the biotech sector.
- Students and Educators: Utilize current data to learn and teach valuation strategies in a real-world context.
What the Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Pacific Biosciences of California, Inc. (PACB).
- Real-World Data: Pacific Biosciences’ historical and projected financials preloaded for thorough analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into performance.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Charts and tables designed for clear, actionable results specific to Pacific Biosciences of California, Inc. (PACB).